CMDh endorses revocation of authorisations for fusafungine sprays used to treat airway infections

View source ↗

Summary

The CMDh endorses the revocation of authorisations for fusafungine nasal sprays and oral sprays used to treat airway infections due to safety concerns.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Airway Infections
• Rhinitis
• Sinusitis

Drugs mentioned

• fusafungine nasal sprays (fusafungine)
• fusafungine oral sprays (fusafungine)